The Latin America, Middle East and Africa Radiation Oncology Market would witness market growth of 14.9% CAGR during the forecast period (2022-2028).
A device that can produce photons or particles, such as electrons, protons, carbon ions, or neutrons, is used to produce radiation energy in the majority of external radiation treatments. The most popular type of radiation oncology is by far high-energy photons (6-20 MV), which are produced by linear accelerators that are readily available on the market. The linear accelerator gantry is free to spin around the treatment table while the patients are reproducibly positioned on a fixed treatment table, with radiation being delivered onto the patient's tumor from various angles.
Using radioactive sources, radiation can also be applied to the tissue nearby or termed brachytherapy. Technology advancements have occasionally made it possible to treat tumors more effectively from a therapeutic standpoint. The usefulness of a novel radiation technology depends on several variables, such as the inherent radio responsiveness of the tumor, the vulnerability of the nearby normal tissue to radiation injury, and the non-radiotherapeutic treatments that are available for a certain cancer diagnosis.
African countries' awareness of the growing health danger posed by non-communicable diseases (NCDs), such as cancer, was underlined by the Brazzaville Declaration on Noncommunicable Disease Prevention and Control in the WHO African Region, issued in 20112. In addition to creating prevention and control plans, the signatories pledged to improve their health systems to reduce NCD burdens, raise funds to fight these illnesses, and support the production of NCD-related data by their national health information systems.
The Brazil market dominated the LAMEA Radiation Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $273.7 million by 2028.The Argentina market is experiencing a CAGR of 15.5% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 14.6% during (2022 - 2028).
Based on Application, the market is segmented into Breast Cancer, Gynecological Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Head & Neck Cancer, Gynecological Cancer and Others. Based on Type, the market is segmented into External Beam Radiation Therapy and Internal Beam Radiation Therapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Radiation Oncology Market is Predict to reach $12.8 Billion by 2028, at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.
By Application
By Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 